InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Keros Therapeutics, Inc.

KROS Clue Score73
United States Fiscal year ends December CIK 0001664710 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Jasbir Seehra
2 Apr 2026
Chief Executive Officer
Exercised, kept
55,000
$0.30
$16.50K
Jasbir Seehra
4 Apr 2025
Chief Executive Officer
Exercised, kept
49,367
$0.30
$14.81K
Jasbir Seehra
8 Apr 2023
Chief Executive Officer
Exercised, kept
4,000
$0.48
$1.92K
Jennifer Lachey
14 Jun 2022
Chief Scientific Officer
Exercised, kept
9,400
$0.30
$2.82K
Jasbir Seehra
9 Jun 2022
Chief Executive Officer
Exercised, kept
5,000
$0.30
$1.50K
Jennifer Lachey
17 Aug 2021
Chief Scientific Officer
Exercised, kept
1,293
$0.30
$387.90
Jennifer Lachey
24 Jun 2021
Chief Scientific Officer
Exercised, kept
6,500
$0.30
$1.95K
Jennifer Lachey
13 May 2021
Chief Scientific Officer
Exercised, kept
500
$0.30
$150.00
Jennifer Lachey
13 May 2021
Chief Scientific Officer
Exercised, kept
6,220
$0.11
$684.20
Showing 250 of 403 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 174
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 72
Sales at will 274
Transactions with no price 0
Shares from compensation/vesting 18,653,788
Sales filed before the plan box existed 256
History held since 8 Apr 2020